Sign in
4

Changes in Ownership

Lipocine Inc. Filed Acc 0001493152-22-030909

Options or other derivatives

  • Chief Medical Officer acquired 125,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Nomikos George Chief Medical Officer 2022-11-01 Grant or award · Stock Option (Right to Buy) +125,000 $0.41 $50,750 125,000 D
Loading xslF345X03/ownership.xml…